Hexarelin

Research Goal: Analyzing peak GH pulse amplitude and the protective effects of Hexarelin on cardiac myocytes via CD36 receptors.

Route

Subcutaneous injection

Dose range

100 mcg – 200 mcg

Frequency

Once daily (due to desensitization risk)

Cycle length

4 weeks on, followed by a 4-week washout to maintain pituitary sensitivity

Not currently stocked by N1 Aminos. Browse what is in stock →

Overview

Research Goal: Analyzing peak GH pulse amplitude and the protective effects of Hexarelin on cardiac myocytes via CD36 receptors.

Preparation: Reconstitute with 2.0 mL bacteriostatic water (Conc: 1 mg/mL or 2.5 mg/mL).

Studied benefits

  • One of the strongest GHRPs available, known for providing a massive spike in Growth Hormone
  • It also offers unique heart-protective (cardioprotective) properties and is used for intense recovery and strength building

Reported side effects

  • Carries the highest risk of receptor desensitization (tachyphylaxis) among GHRPs, necessitating regular cycling
  • It may also cause temporary increases in cortisol and prolactin

Protocol

Dosing Schedule (Subcutaneous)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

PhaseDaily Dose (mcg)Draw at 2.5 mg/mLLog
Standard100 mcg4 units (0.04 mL)+ Log
Advanced200 mcg8 units (0.08 mL)+ Log

Frequency

Once daily (due to desensitization risk).

Timing

Evening or immediately post-training.

Cycle length

4 weeks on, followed by a 4-week washout to maintain pituitary sensitivity.

Unit calculator

Set your vial and water; the table above updates.

Open the full calculator →
Concentration

2.5 mg/mL

50 doses of 100 mcg per vial

At the starting dose (100 mcg × 7/week for a 4-week cycle) you would use about 2.8 mg, i.e. 1 × 5 mg vial. Higher phases use proportionally more.

Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.

Context

Lifestyle considerations

Maintain a high-protein, nutrient-dense diet to support the profound GH release and potential cardioprotective effects associated with this potent growth hormone secretagogue. Incorporate resistance training to maximize the improvements in strength and recovery, but monitor cardiovascular markers periodically as part of a comprehensive research protocol. Ensure 7–9 hours of quality sleep to facilitate cellular repair and synchronize with natural hormonal rhythms. Because Hexarelin can cause rapid receptor desensitization, implement a "pulsing" schedule (such as 2 weeks on, 1 week off) to maintain sensitivity and consistent performance.

Evidence

Research summaries

Growth hormone secretagogues: history, mechanism of action, and clinical development

Findings: Strong GH pulses, works orally sometimes, potential for heart and muscle wasting fixes.

Hexarelin, a GHRP family star, blasts GH harder than GHRP-6 via ghrelin mimic paths. Human trials show big spikes IV/subQ, milder oral. Unlike natural GHRH, no quick fade. Early tests for GH deficiency, cachexia (muscle loss), heart failure – improved strength, ejection fraction. Sides minimal: hunger, water retention. Evolved to pills like ibutamoren. Sets stage for age-related GH drop therapies. Turbo GH without daily shots.

Read the study ↗

Growth hormone-releasing peptides and their analogs

Findings: Potent GH in animals/humans, non-GHRH path for steady boosts, leads to oral drugs.

Hexarelin outpowers earlier GHRPs in rats, beagles, humans – GH jumps 10-20x baseline. Acts on unique receptors, synergizes with GHRH. Pushed field to small-molecule mimics for easy dosing. Used in obesity, frailty studies for fat loss/muscle gain. Reliable across species, hinting human longevity perks.

Read the study ↗

Agonists of growth hormone-releasing hormone (GHRH) receptor inhibit experimental lung cancer... (notes hexarelin parallels)

Findings: GH pathway for anti-cancer synergy, organ protection like heart/lungs.

While GHRH-focused, hexarelin-like secretagogues shrink tumors, aid radiation. Heart post-MI recovery, diabetes eye fixes in animals. Hexarelin's potency amps these. Broad repair: wounds, arteries. Emerging for non-growth uses.

Read the study ↗

Effect of GHRH and GHRP-2 treatment... (extends to hexarelin family)

Findings: Synergy for max GH, cell morphology tweaks for sustained release.

GHRP family incl. hexarelin analogs up GH receivers, Pit-1 genes in sheep cells. With GHRH, explosive output. Changes cell shape for better signaling. Foundation for blends in therapy.

Read the study ↗
More references (5)

Identification

Chemistry

cas
140703-51-1 (primary)
formula
C₄₇H₅₈N₁₂O₆ (free peptide); may vary with salt forms
molecular weight
887.0-887.04 g/mol (free peptide); varies with salt forms
sequence
H-His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH₂ (single-letter code: HMAWFK with D-stereocenters and 2-methyl substitution)
source
Synthetic; rationally designed derivative of GHRP-6
biosynthesis
Non-ribosomal; chemically synthesized through peptide bond formation
type
Linear peptide; C-terminal amidation; contains D-amino acids and 2-methyl-modified tryptophan

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor